SMI
11.781,74
PKT
+79,17
PKT
+0,68
%
Werbung
Analysen zu SMI-Werten
Datum | Rating | Analyst | |
---|---|---|---|
04.04.18 | Nestlé Outperform | RBC Capital Markets | |
03.04.18 | Swiss Re overweight | JP Morgan Chase & Co. | |
03.04.18 | Roche overweight | JP Morgan Chase & Co. | |
03.04.18 | ABB (Asea Brown Boveri) Conviction Buy List | Goldman Sachs Group Inc. | |
03.04.18 | Nestlé Neutral | UBS AG | |
03.04.18 | UBS buy | UBS AG | |
29.03.18 | Zurich Insurance Neutral | UBS AG | |
29.03.18 | Swiss Re Neutral | Goldman Sachs Group Inc. | |
29.03.18 | Swiss Re overweight | Barclays Capital | |
29.03.18 | Swiss Re Sector Perform | RBC Capital Markets | |
29.03.18 | Roche Hold | Deutsche Bank AG | |
28.03.18 | ABB (Asea Brown Boveri) Neutral | JP Morgan Chase & Co. | |
28.03.18 | Novartis buy | Oddo Seydler Bank AG | |
28.03.18 | Zurich Insurance Equal weight | Barclays Capital | |
28.03.18 | Novartis Hold | Deutsche Bank AG | |
27.03.18 | Novartis buy | S&P Capital IQ | |
27.03.18 | Novartis buy | Baader Bank | |
27.03.18 | Novartis Neutral | UBS AG | |
27.03.18 | Givaudan Neutral | Goldman Sachs Group Inc. | |
27.03.18 | UBS Outperform | Credit Suisse Group | |
27.03.18 | Givaudan Hold | Kepler Cheuvreux | |
27.03.18 | Roche Conviction Buy List | Goldman Sachs Group Inc. | |
27.03.18 | Roche overweight | JP Morgan Chase & Co. | |
27.03.18 | Nestlé overweight | JP Morgan Chase & Co. | |
27.03.18 | Givaudan overweight | JP Morgan Chase & Co. | |
27.03.18 | Roche Underweight | Morgan Stanley | |
27.03.18 | Givaudan Hold | Deutsche Bank AG | |
26.03.18 | Nestlé Outperform | RBC Capital Markets | |
26.03.18 | Givaudan Neutral | Goldman Sachs Group Inc. | |
23.03.18 | UBS overweight | Morgan Stanley | |
23.03.18 | Roche buy | Jefferies & Company Inc. | |
23.03.18 | Swiss Re buy | Deutsche Bank AG | |
21.03.18 | Roche Hold | Deutsche Bank AG | |
21.03.18 | Holcim Hold | Deutsche Bank AG | |
21.03.18 | Nestlé buy | Goldman Sachs Group Inc. | |
20.03.18 | Roche Conviction Buy List | Goldman Sachs Group Inc. | |
20.03.18 | Roche Neutral | UBS AG | |
20.03.18 | Roche overweight | JP Morgan Chase & Co. | |
20.03.18 | Givaudan Sell | Citigroup Corp. | |
19.03.18 | Zurich Insurance Neutral | UBS AG |
* Die angezeigten Realtime Kurse sind indikativ und nicht die offiziellen Börsenkurse. Die Kursdaten können eventuell vom tatsächlichen Marktpreis abweichen.